Assessment of 18F-Florbetaben Amyloid PET Imaging in Patients with Suspected Alzheimer's Disease and Isolated Increase in Cerebrospinal Fluid Tau Proteins.
Fiche publication
Date publication
mars 2019
Journal
Journal of Alzheimer's disease : JAD
Auteurs
Membres identifiés du Cancéropôle Est :
Pr KARCHER Gilles, Pr MARIE Pierre-Yves, Pr VERGER Antoine
Tous les auteurs :
Manca C, Hopes L, Kearney-Schwartz A, Roch V, Karcher G, Baumann C, Marie PY, Malaplate-Armand C, Rivasseau Jonveaux T, Verger A
Lien Pubmed
Résumé
The aim of this study was to assess, in routine, the rates with which an amyloid deposition was documented by 18F-florbetaben PET in patients with suspected Alzheimer's disease (AD) but with isolated increases in cerebrospinal fluid (CSF) tau-protein concentrations, and the subsequent impact of these PET results on medical management.
Référence
J. Alzheimers Dis.. 2019 Mar 11;: